Skip to main content

Table 2 Inter-reader agreement for central pathologists with HER2-low training

From: Accuracy of human epidermal growth factor receptor 2 (HER2) immunohistochemistry scoring by pathologists in breast cancer, including the HER2-low cutoff

HER2 IHC score cutoff

OPA, % (95% CI)

Fleiss’ kappa

Pathologists

1 vs. 2

Pathologists

2 vs. 3

Pathologists

1 vs. 3

0 absent membrane staininga, b vs. 0 with membrane staininga 1+, 2+, 3+

96 (93–97)

96 (94–98)

97 (95–99)

0.68

0c vs. 1+, 2+, 3+

94 (92–96)

94 (92–96)

91 (88–94)

0.79

0, 1 + vs. 2+, 3+

85 (81–88)

85 (81–88)

94 (90–95)

0.74

0, 1+, 2 + vs. 3+

97 (95–98)

87 (84–90)

87 (84–90)

0.67

  1. CI: confidence interval; HER2: human epidermal growth factor receptor 2; IHC: immunohistochemistry; OPA: overall percent agreement
  2. a “IHC 0 absent membrane staining” and “IHC 0 with membrane staining” are part of the IHC 0 score per American Society of Clinical Oncology/College of American Pathologists 2018 guidelines [2]
  3. b Cutoff explored in DESTINY-Breast06 [17]
  4. c Cutoff for HER2-low used in DESTINY-Breast04 [12]